The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Jonathan J. Havel, Diego Chowell, Timothy An-thy Chan

View at source ↗Review2,285 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/s41568-019-0116-x
Published
Feb 12, 2019
Venue
Nature reviews. Cancer
DOI
10.1038/s41568-019-0116-x
PubMed
30755690
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics